Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples